Tilbake til søkeresultatene

PES2020-Prosj.etabl.støtte H2020

Production technology for GE-tobacco as a molecular factory for production of vaccines.

Tildelt: kr 0,12 mill.

Intravision Group is a bio-light and systems integration company working with new technologies for production of foods and plant made pharmaceuticals. Our focus is on multi-band and spectrum variable LED lights enabling biological control and optimization of plant responses to specific wavelengths between UVA and IR light. We both initiate and partake in associated research projects. We are headquartered in Oslo, Norway, with offices in Shenzhen, China , and Toronto, Ontario, Canada. Background: Intravision Group AS (IVG) Norway and the Canadian company PlantForm Corporation (PFC) have established cooperation on development of IVG?s; GravityFlow system, a novel automated production technology for PlantForm?s biopharmaceutical tobacco-plant-based production system, vivoXPRESS?. The partner: PlantForm (PFC) is a biotechnology company developing high-value antibody and protein drugs using its proprietary IP: A low-cost tobacco-plant-based production system, vivoXPRESS?. The Company is applying the technology in three business areas (1) Biosimilar (?generic?) versions of biologic (large molecule) prescription drugs. (2) Drugs as countermeasures to bioterrorism. (3) Contract projects for other parties, a substantial part of this being vaccines, including HIV, Ebola and Zika. The EUROSTAR application target the development of IVG's GravityFlow production system specifically for applications within Vaccine applications, where we plan to focus specifically on "time to produce vaccines through vivoXPRESS, shorten the GravityFlow production cycle, scalability of the GF technology, aiming to offer this technology as a low-cost and highly efficient model for vaccine production.


PES2020-Prosj.etabl.støtte H2020